… leading to differential presentation to primary care or the hospital, or changes in the
management of cases with underlying comorbidities and other risk factors. Evaluation of vaccine …

… of PCV15 serotypes in the United States [63] and Europe [64] and found directionally similar
… , both in terms of the incidence of overall disease, as well as potential changes in underlying …

… of children by clinicians over time, an increased risk of death in the most vulnerable cases
and therefore surviving children are simply at lower risk, or underlying comorbidities and …

… that invasive pneumococcal disease, and particularly recurrent IPD, is an important marker
of underlying PID in children without other risk factors. … in the European routine vaccination …

… and risk factors for non-invasive pneumonia in children <15 … be a residual burden of pediatric
pneumococcal diseases in the … impact the burden of IPD and non-invasive pneumonia will …

… Risk factors for pneumococcal disease … The presence of underlying conditions and phenomena
such as … among adults even with the indirect effects of the pediatric PCV13 vaccination …

… -invasive pneumococcal disease, hospitalisation and mortality in adults before and after the
introduction of PCV13 for children … to achieve the current US and European goals, especially …

… Similar results for serotype 8 have been reported in other European countries such as …
schedules, inclusion of risk factors, and the impact of carriage and invasiveness among the …

… include data on invasive pneumococcal disease incidence and/… 1.19) in the UK [11] and in
children <2 years in Germany [36]. … of invasive pneumococcal disease incidence in children (…

… vaccination coverage in PLWH is low in Europe and the United States, despite longstanding
… Additionally, we aimed to identify risk factors for pneumococcal disease in PLWH. …